A group of U.S. senators is urging a bankruptcy judge to prevent Purdue Pharma from paying its chief executive officer, Craig Landau, a bonus worth up to $3.5 million, because he may have overseen “criminal activity” during his tenure at the infamous opioid maker.

Earlier this year, U.S. Bankruptcy Judge Robert Drain decided that Purdue was justified in giving Landau a bonus because it would help to keep him at the company, where he has been chief executive since June 2017. Purdue filed for bankruptcy a year ago as part of a tentative agreement with 24 states and thousands of cities and counties that sought to recover damages incurred by the opioid crisis.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy